Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | February 6, 2020 |
| Target | Assertio Therapeutics - NUCYNTA |
| Sector | Life Science |
| Buyer(s) | Collegium Pharmaceutical |
| Sellers(s) | Assertio |
| Deal Type | Divestiture |
| Deal Value | 375M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2002 |
| Sector | Life Science |
| Employees | 357 |
| Revenue | 631M USD (2024) |
Collegium Pharmaceutical provides specialty pharmaceutical services by developing and planning to commercialize next-generation, abuse-deterrent products for patients suffering from chronic pain. Collegium Pharmaceutical was founded in 2002 and is based in Stoughton, Massachusetts.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science | 1 of 3 |
| Type: Divestiture | 1 of 1 |
| State: California | 1 of 1 |
| Country: United States | 1 of 3 |
| Year: 2020 | 1 of 1 |
| Size (of disclosed) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-14 |
BioDelivery
Raleigh, North Carolina, United States BioDelivery is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of differentiated pain and neurology products and leverages its experienced sales and marketing organization to educate prescribers on their unique features. BioDelivery was formed in 1997 and is based in Raleigh, North Carolina. |
Buy | $604M |
| Category | Company |
|---|---|
| Founded | 1995 |
| Sector | Life Science |
| Employees | 58 |
| Revenue | 125M USD (2024) |
Assertio is a pharmaceutical company focused on products to treat pain and other central nervous system (CNS) conditions. Assertio was founded in 1995 and is based in Lake Forest, Illinois.
| Deal Context for Seller | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 2 of 2 |
| Type: Divestiture | 3 of 3 |
| State: California | 2 of 2 |
| Country: United States | 3 of 3 |
| Year: 2020 | 2 of 2 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-13 |
Assertio Therapeutics - Gralise Business
Newark, California, United States Assertio Therapeutics, Inc. - Gralise Business is a prescription medicine used to treat pain after shingles, or postherpetic neuralgia (PHN). |
Sell | $128M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-03-16 |
Zyla Life Sciences
Wayne, Pennsylvania, United States Zyla Life Sciences is a business committed to bringing important products to patients and healthcare providers. Zyla is focused on marketing its portfolio of medicines for pain and inflammation. Zyla Life Sciences portfolio includes six products: SPRIX® (ketorolac tromethamine) Nasal Spray, ZORVOLEX® (diclofenac), VIVLODEX® (meloxicam), INDOCIN® (indomethacin) suppositories, INDOCIN® oral suspension and OXAYDO® (oxycodone HCI, USP) tablets for oral use only - CII. Zyla Life Sciences was founded in 2010 and is based in Wayne, Pennsylvania. |
Buy | - |
